Overview
Alejandra Caminoa practices practicing medicine in Madrid, Spain.
Her clinical expertise encompasses Familial Pancreatic Cancer, Lung Cancer, and Pancreatic Cancer.
She is actively involved in clinical research, co-authoring 13 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Alejandra Caminoa
Is Alejandra Caminoa a top-rated expert for Familial Pancreatic Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Alejandra Caminoa is classified as an Experienced expert for Familial Pancreatic Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Alejandra Caminoa participate in research or clinical trials?
Yes. Alejandra Caminoa has published 13 articles and abstracts on conditions like Familial Pancreatic Cancer. You can view a list of Alejandra Caminoa's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Familial Pancreatic CancerMs. Caminoa isExperienced. Learn about Familial Pancreatic Cancer.
- Lung CancerMs. Caminoa isExperienced. Learn about Lung Cancer.
- Pancreatic CancerMs. Caminoa isExperienced. Learn about Pancreatic Cancer.